Treace Medical: Scanlan disposes of 207 shares

The reported post-transaction position includes restricted stock units and reflects a transfer to Scanlan's former spouse pursuant to a domestic relations order.

Rhea-AI Filing Summary

Treace Medical Concepts, Inc. (TMCI) Chief Innovation Officer Sean F. Scanlan reported that on October 24, 2026, 207 common shares were delivered or withheld for payment of exercise price or tax liability. His reported direct holdings afterward were 634,656 shares, including 462,317 restricted stock units; the reported amount reflects a transfer of 45,000 common shares to his former spouse pursuant to a domestic relations order. No Rule 10b5-1 plan is reported.

Insider Trade Summary

Exercise Price or Tax Liability: 207 shares

Exercise Price or Tax Liability 1 txn

Insider Scanlan Sean F.

Role Chief Innovation Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock F1, F2	207	$0.00	$0.00

Holdings After Transaction: Common Stock — 634,656 shares (Direct)

Footnotes (2)

1. F1. Includes 462,317 restricted stock units.
2. F2. Reflects the transfer of 45,000 shares of common stock to the reporting person's former spouse pursuant to a domestic relations order.

Key Figures

Shares delivered or withheld: 207 shares Direct holdings after transaction: 634,656 shares Restricted stock units: 462,317 restricted stock units +1 more

4 metrics

Shares delivered or withheld 207 shares For payment of exercise price or tax liability on October 24, 2026

Direct holdings after transaction 634,656 shares Reported post-transaction amount

Restricted stock units 462,317 restricted stock units Included in reported post-transaction holdings

Transfer to former spouse 45,000 common shares Pursuant to a domestic relations order; reflected in the reported post-transaction amount

Key Terms

restricted stock units, domestic relations order, exercise price or tax liability

3 terms

restricted stock units financial

"Includes 462,317 restricted stock units."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

domestic relations order other

"transfer of 45,000 shares of common stock to the reporting person's former spouse pursuant to a domestic relations order"

exercise price or tax liability financial

"Payment of exercise price or tax liability by delivering or withholding securities"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What transaction did TMCI Chief Innovation Officer Sean F. Scanlan report?

Sean F. Scanlan reported 207 common shares delivered or withheld for payment of exercise price or tax liability on October 24, 2026. No Rule 10b5-1 plan is reported.

How many TMCI shares did Sean F. Scanlan report holding after the transaction?

Scanlan reported direct holdings of 634,656 shares after the transaction. The amount includes 462,317 restricted stock units and reflects a transfer of 45,000 common shares to his former spouse pursuant to a domestic relations order.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/28/2026 - 07:30 PM EDT Accepted by SEC EDGAR 10/28/2026 - 07:30 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Scanlan Sean F.

(Last) (First) (Middle)

C/O TREACE MEDICAL CONCEPTS, INC.

100 PALMETTO PARK PLACE

(Street)

PONTE VEDRA FLORIDA 32081

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TREACE MEDICAL CONCEPTS, INC. [ TMCI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Innovation Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/24/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/24/2026		F		207	D	$0	634,656(1)(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 462,317 restricted stock units.

2. Reflects the transfer of 45,000 shares of common stock to the reporting person's former spouse pursuant to a domestic relations order.

	/s/ Lisa Taylor as Attorney-in-fact for Sean Scanlan	10/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)